Skip to main content
. 2019 Feb 18;12(2):207–211. doi: 10.18240/ijo.2019.02.04

Table 2. Th lymphocyte subsets in patients with VKH disease.

Characteristics Active VKH patients Inactive VKH patients Healthy controls aP bP cP
Th1 23.42±5.98 13.57±7.00 17.58±6.60 0.03 0.17 0.01
Th2 1.64±0.79 2.54±1.79 2.04±0.81 0.23 0.46 0.06
Th1/Th2 14.3±7.16 7.38±5.65 8.45±3.68 0.02 0.35 0.02
Th17 37.47±14.53 17.23±9.87 25.97±5.35 0.001 0.05 0.03
Treg 2.00±1.77 4.26±1.70 5.60±2.06 0.04 0.08 0.04
Th17/Treg 10.63±3.35 7.84±6.35 4.81±1.66 0.001 0.06 0.04

VKH: Vogt-Koyanagi-Harada. aHealthy controls vs active patients; bHealthy controls vs inactive patients; cActive patients vs inactive patients.

mean±SD, pg/mL